158 related articles for article (PubMed ID: 37364415)
21. Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice.
Liang QQ; Shi ZJ; Yuan T; Chen SY; Li YP; Zhang HR; You YP; Xu R; Xu LH; Hu B; Ouyang DY; Zha QB; He XH
Int Immunopharmacol; 2023 Apr; 117():109974. PubMed ID: 37012867
[TBL] [Abstract][Full Text] [Related]
22. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis.
Shi FL; Yuan LS; Wong TS; Li Q; Li YP; Xu R; You YP; Yuan T; Zhang HR; Shi ZJ; Zha QB; Hu B; He XH; Ouyang DY
Pharmacol Res; 2023 Mar; 189():106697. PubMed ID: 36796462
[TBL] [Abstract][Full Text] [Related]
23. Potent Inhibition of Necroptosis by Simultaneously Targeting Multiple Effectors of the Pathway.
Pierotti CL; Tanzer MC; Jacobsen AV; Hildebrand JM; Garnier JM; Sharma P; Lucet IS; Cowan AD; Kersten WJA; Luo MX; Liang LY; Fitzgibbon C; Garnish SE; Hempel A; Nachbur U; Huang DCS; Czabotar PE; Silke J; van Delft MF; Murphy JM; Lessene G
ACS Chem Biol; 2020 Oct; 15(10):2702-2713. PubMed ID: 32902249
[TBL] [Abstract][Full Text] [Related]
24. Structure-Based Design of Novel Alkynyl Thio-Benzoxazepinone Receptor-Interacting Protein Kinase-1 Inhibitors: Extending the Chemical Space from the Allosteric to ATP Binding Pockets.
Quan D; Hou R; Shao H; Zhang X; Yu J; Zhang W; Yuan H; Zhuang C
J Med Chem; 2023 Feb; 66(4):3073-3087. PubMed ID: 36724216
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
26. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
27. Protein-Bound Polysaccharides from
Pawlikowska M; Jędrzejewski T; Brożyna AA; Wrotek S
Cell Physiol Biochem; 2020 Jun; 54(4):591-604. PubMed ID: 32531147
[TBL] [Abstract][Full Text] [Related]
28. Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.
Zhuang C; Chen F
J Med Chem; 2020 Feb; 63(4):1490-1510. PubMed ID: 31622096
[TBL] [Abstract][Full Text] [Related]
29. Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1.
Wang ZW; Zou FM; Wang AL; Yang J; Jin R; Wang BL; Shen LJ; Qi S; Liu J; Liu J; Wang WC; Liu QS
Acta Pharmacol Sin; 2023 Apr; 44(4):801-810. PubMed ID: 36216899
[TBL] [Abstract][Full Text] [Related]
30. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
[TBL] [Abstract][Full Text] [Related]
31. CAMK2/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux.
Zhan Q; Jeon J; Li Y; Huang Y; Xiong J; Wang Q; Xu TL; Li Y; Ji FH; Du G; Zhu MX
Autophagy; 2022 Apr; 18(4):726-744. PubMed ID: 34282994
[TBL] [Abstract][Full Text] [Related]
32. Identification of Pyrido[3,4-d]pyrimidine derivatives as RIPK3-Mediated necroptosis inhibitors.
Kim N; Park CJ; Kim Y; Ryu S; Cho H; Nam Y; Han M; Shin JS; Sim T
Eur J Med Chem; 2023 Nov; 259():115635. PubMed ID: 37494773
[TBL] [Abstract][Full Text] [Related]
33. Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity.
Hao Y; Yang C; Shu C; Li Z; Xia K; Wu S; Ma H; Tian S; Ji Y; Li J; He S; Zhang X
Bioorg Chem; 2022 Dec; 129():106051. PubMed ID: 36115309
[TBL] [Abstract][Full Text] [Related]
34. Ophiopogonin D' induces RIPK1‑dependent necroptosis in androgen‑dependent LNCaP prostate cancer cells.
Lu Z; Wu C; Zhu M; Song W; Wang H; Wang J; Guo J; Li N; Liu J; Li Y; Xu H
Int J Oncol; 2020 Feb; 56(2):439-447. PubMed ID: 31894265
[TBL] [Abstract][Full Text] [Related]
35. Luteolin ameliorates necroptosis in Glucocorticoid-induced osteonecrosis of the femoral head via RIPK1/RIPK3/MLKL pathway based on network pharmacology analysis.
Xu X; Fan X; Wu X; Xia R; Liang J; Gao F; Shu J; Yang M; Sun W
Biochem Biophys Res Commun; 2023 Jun; 661():108-118. PubMed ID: 37099894
[TBL] [Abstract][Full Text] [Related]
36. Phenytoin inhibits necroptosis.
von Mässenhausen A; Tonnus W; Himmerkus N; Parmentier S; Saleh D; Rodriguez D; Ousingsawat J; Ang RL; Weinberg JM; Sanz AB; Ortiz A; Zierleyn A; Becker JU; Baratte B; Desban N; Bach S; Schiessl IM; Nogusa S; Balachandran S; Anders HJ; Ting AT; Bleich M; Degterev A; Kunzelmann K; Bornstein SR; Green DR; Hugo C; Linkermann A
Cell Death Dis; 2018 Mar; 9(3):359. PubMed ID: 29500402
[TBL] [Abstract][Full Text] [Related]
37. The Bcr-Abl inhibitor DCC-2036 inhibits necroptosis and ameliorates osteoarthritis by targeting RIPK1 and RIPK3 kinases.
Piao L; Wu D; Rui C; Yang Y; Liu S; Liu J; Jin Z; Zhang H; Feng X; Bai L
Biomed Pharmacother; 2023 May; 161():114528. PubMed ID: 36931029
[TBL] [Abstract][Full Text] [Related]
38. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
Yu X; Mao M; Liu X; Shen T; Li T; Yu H; Zhang J; Chen X; Zhao X; Zhu D
J Mol Med (Berl); 2020 Apr; 98(4):569-583. PubMed ID: 32072232
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel 2,8-diazaspiro[4.5]decan-1-one derivatives as potent RIPK1 kinase inhibitors.
Niu A; Lin L; Zhang D; Jiang K; Weng D; Zhou W; Wang J
Bioorg Med Chem; 2022 Apr; 59():116686. PubMed ID: 35228069
[TBL] [Abstract][Full Text] [Related]
40. Discovery of novel 5-phenylpyrazol receptor interacting protein 1(RIP1) kinase inhibitors as anti-necroptosis agents by combining virtual screening and in vitro and in vivo experimental evaluations.
Shi Y; Tang J; Zhi S; Jiang R; Huang Q; Sun L; Wang Z; Wu Y
Bioorg Chem; 2024 Jan; 142():106964. PubMed ID: 37976678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
